Canaan Partners X LLC, 10% Owner at Protagonist Therapeutics, Inc (PTGX), sold 77,936 shares at $6.09 ($475K) on 2018-05-17, disclosed to the SEC on 2018-05-21.
Open-market sale of $475k PTGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.09 | 38,968 | $237K | 50.0% |
| 2 | $6.09 | 38,968 | $237K | 50.0% |
| Total | $6.09 avg | 77,936 | $475K | 100% |
| Filing → |
| PTGX | SELL | 2018-03-19 | $837K | — | Filing → |
| PTGX | SELL | 2018-03-15 | $514K | — | Filing → |